ViiV Healthcare announced the recipients of an $8-million investment to increase awareness and action around HIV prevention and care for Black women, according to a press release via CSR Wire.
Funding will support community programs focused on highlighting women’s reasons for HIV prevention, connecting women to care, training service providers, and changing the narrative about HIV and Black women. Over the next three years, 17 community-based organizations will reach more than one million people with reasons for HIV prevention and train more than 3,500 community providers to deliver HIV services to Black women better.
ViiV Healthcare Senior Vice President of Head of Research & Development Dr. Kimberly Smith said, “With this—the largest fund in the U.S. dedicated to Black women and HIV—we are doubling down on our commitment to fuel a wave of action aimed at disrupting the disparities that keep Black women from engaging in HIV prevention and care.”
Grantmaking is among the key pillars of Risk to Reasons—an expansion of the ViiV Healthcare Positive Action for Women community program that focuses on women of color. Risk to Reasons was launched this year, guided by the Black Women’s Working Group to Reframe Risk, a group of women living with and working in HIV.
The grantee organizations include
—Advocates for Youth
—African Services Committee
—AIDS United
—Black Ladies in Public Health Foundation
—CAL-PEP
—Multicultural AIDS Coalition Inc.
—National Network to End Domestic Violence
—Planned Parenthood of Metropolitan Washington DC Inc.
—Positive People Network
—Prevention Access Campaign, a program of fiscal sponsor Social and Environmental Entrepreneurs
—Professional Association of Social Workers in HIV/AIDS
—The Center for Black Health & Equity
—The Community Health & Empowerment Network, Inc.
—The Community Wellness Project
—The Knights & Orchids Society
—Transforming Re-Entry Services
—WeCareTN
For more information, visit http://viivhealthcare.com/en-us/supporting-the-hiv-community/positive-action/women-living-with-hiv.